Placebo News and Research

RSS

Viagra in pregnancy trial stopped after 11 newborn babies died

A Dutch clinical trial was looking at the potential of Sildenafil or impotence drug Viagra to improve the growth in unborn babies of pregnant women. The study had to be stopped prematurely after the death of eleven babies.

25 Jul 2018

Common opioid-based painkillers increase harmful side effects in people with dementia

Commonly-prescribed opioid-based painkillers led to harmful side effects tripling in people with dementia.

24 Jul 2018

New study finds brain mechanisms underlying food cravings

A newly published study from the University of Waterloo shows that when activity in a specific part of the brain is suppressed, our desire for high-calorie foods increases.

23 Jul 2018

Researchers study efficacy and safety of new treatment for OUD

Better delivery of medications to treat opioid use disorder is key to addressing the opioid crisis and helping the 2.6 million Americans affected by the disease.

20 Jul 2018

ADHD medications may fail to improve cognition in healthy college students, study shows

Contrary to popular belief across college campuses, attention deficit hyperactivity disorder medications may fail to improve cognition in healthy students and actually can impair functioning, according to a study by researchers at the University of Rhode Island and Brown University.

20 Jul 2018

New Finnish study compares surgical treatment of shoulder impingement syndrome to placebo surgery

In a landmark study published this week in the BMJ, Finnish researchers show that one of the most common surgical procedures in the Western world is probably unnecessary.

19 Jul 2018

New clinical trial examines use of adrenaline to treat cardiac arrests

A clinical trial of the use of adrenaline in cardiac arrests has found that its use results in less than 1% more people leaving hospital alive - but almost doubles the risk of severe brain damage for survivors of cardiac arrest.

19 Jul 2018

Phase 3 study of tanezumab in patients with osteoarthritis pain meets all three co-primary endpoints

Pfizer Inc. and Eli Lilly and Company today announced that a 16-week Phase 3 study in patients with osteoarthritis pain evaluating subcutaneous administration of tanezumab, an investigational humanized monoclonal antibody, met all three co-primary endpoints.

19 Jul 2018

New findings do no support caffeine as effective appetite suppressant or weight-loss aid

A new study featured in the Journal of the Academy of Nutrition and Dietetics found that after drinking a small amount of caffeine, participants consumed 10 percent less at a breakfast buffet provided by researchers, but this effect did not persist throughout the day and had no impact on participants' perceptions of their appetites.

19 Jul 2018

FDA grants approval for first breast cancer drug through 'Real-Time Oncology Review'

The U.S. Food and Drug Administration today approved Kisqali (ribociclib) in combination with an aromatase inhibitor for the treatment of pre/perimenopausal or postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer, as initial endocrine-based therapy.

19 Jul 2018

Increasing blood sugar levels improves memory and performance in older adults

Sugar improves memory in older adults - and makes them more motivated to perform difficult tasks at full capacity - according to new research by the University of Warwick.

18 Jul 2018

New study demonstrates little effect of hormone therapy on artery thickness

Heart disease is still the number one killer of US women, and hormone therapy remains a top treatment for menopause symptoms.

18 Jul 2018

Testosterone effective at fighting cachexia in cancer patients, research shows

Many cancer patients suffer from a loss of body mass known as cachexia. Approximately 20 percent of cancer-related deaths are attributed to the syndrome of cachexia, which in cancer patients is often characterized by a rapid and/or severe loss of fat and skeletal muscle.

13 Jul 2018

Captozyme begins cross-over study of Nephure oxalate reducing enzyme

Captozyme, Inc. announced today that it is initiating a prospective double-blind, randomized, placebo controlled, cross-over study, with Nephure, an oxalate reducing enzyme, to determine the extent to which Nephure vs. placebo reduces urinary oxalate excretion (mg/24 hour) in healthy subjects who are provided a controlled diet.

12 Jul 2018

Neurotransmitter responsible for brain arousal plays vital role in early sensory perceptions

Being aware of our surroundings is a fundamental aspect of our existence. But what in our biological makeup determines how we access and interpret the endless stream of information around us?

10 Jul 2018

Human trial identifies common blood pressure medication as safe, effective therapy for diabetes

Researchers at the University of Alabama at Birmingham Comprehensive Diabetes Center have discovered a safe and effective novel therapy to reduce insulin requirements and hypoglycemic episodes in adult subjects with recent onset Type 1 diabetes by promoting the patient's own beta cell function and insulin production -- the first such discovery to target diabetes in this manner.

9 Jul 2018

Step towards an HIV/AIDS vaccine

There has been a four decades long challenge to develop a vaccine against the deadly HIV virus that causes AIDS. Last Saturday the research bore fruit when a team of scientists announced that a trial drug has shown immune response in humans and also protected laboratory monkeys from HIV infection.

9 Jul 2018

Study offers new hope for people with disabling Dupuytren's disease

Researchers at the Kennedy Institute and Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, working with clinicians at NHS Lothian, have found that injection of the anti-TNF drug adalimumab into Dupuytren's disease nodules results in the reduction of the cell characteristics responsible for progression of Dupuytren's disease.

9 Jul 2018

Violent tendencies could be curbed by brain stimulation

According to a new study, a brain intervention could stop a perverse desire to be physically or sexually violent in some individuals.

4 Jul 2018

Study finds link between testosterone and men's preference for status goods

A recent study conducted by a research team around Hilke Plassmann, the INSEAD Chaired Professor of Decision Neuroscience & Brain and Spine Institute, a principal investigator in the Social Affective Neuroscience Team at the ICM, David Dubois, Associate Professor of Marketing at INSEAD and Gideon Nave, Assistant Professor of Marketing at The Wharton School & the Wharton Neuroscience Initiative shows that testosterone, the male sex hormone, increased men's preference for status goods compared to goods of similar perceived quality but seen as lower in status.

4 Jul 2018

Placebo News and Research

Viagra in pregnancy trial stopped after 11 newborn babies died

Common opioid-based painkillers increase harmful side effects in people with dementia

New study finds brain mechanisms underlying food cravings

Researchers study efficacy and safety of new treatment for OUD

ADHD medications may fail to improve cognition in healthy college students, study shows

New Finnish study compares surgical treatment of shoulder impingement syndrome to placebo surgery

New clinical trial examines use of adrenaline to treat cardiac arrests

Phase 3 study of tanezumab in patients with osteoarthritis pain meets all three co-primary endpoints

New findings do no support caffeine as effective appetite suppressant or weight-loss aid

FDA grants approval for first breast cancer drug through 'Real-Time Oncology Review'

Increasing blood sugar levels improves memory and performance in older adults

New study demonstrates little effect of hormone therapy on artery thickness

Testosterone effective at fighting cachexia in cancer patients, research shows

Captozyme begins cross-over study of Nephure oxalate reducing enzyme

Neurotransmitter responsible for brain arousal plays vital role in early sensory perceptions

Human trial identifies common blood pressure medication as safe, effective therapy for diabetes

Step towards an HIV/AIDS vaccine

Study offers new hope for people with disabling Dupuytren's disease

Violent tendencies could be curbed by brain stimulation

Study finds link between testosterone and men's preference for status goods

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News